- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02757924
Behavior of Infants Fed Formula Supplemented With Prebiotics
June 16, 2017 updated by: Abbott Nutrition
Behavior of Infants Fed a Partially Hydrolyzed Formula Supplemented With Prebiotics
To observe the effects of partially hydrolyzed formula supplemented with oligosaccharides on symptoms of formula intolerance in healthy term infants.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
59
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Dothan, Alabama, United States, 36305
- Southeastern Pediatric Associates
-
-
Florida
-
Pensacola, Florida, United States, 32503
- Pensacola Research Consultants, Inc
-
Saint Petersburg, Florida, United States, 33710
- SCORE Physician Alliance, LLC
-
-
Indiana
-
Evansville, Indiana, United States, 47713
- Deaconess Clinic, Inc.
-
-
Kentucky
-
Bardstown, Kentucky, United States, 40004
- Kentucky Pediatric/Adult Research
-
-
Nebraska
-
Lincoln, Nebraska, United States, 68510
- Women's Clinic of Lincoln, PC
-
-
Ohio
-
Grove City, Ohio, United States, 43123
- Aventiv Research
-
-
South Carolina
-
Charleston, South Carolina, United States, 29414
- Coastal Pediatric Research
-
-
Tennessee
-
Bristol, Tennessee, United States, 37620
- Holston Medical Group
-
Kingsport, Tennessee, United States, 37660
- Holston Medical Group
-
-
Texas
-
San Antonio, Texas, United States, 78229
- Southwest Children's Research Associates, P.A.
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 week to 1 month (CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Subject is judged to be in good health.
- Subject is a singleton from a full-term birth with a gestational age of 37 - 42 weeks.
- Subject's birth weight was ≥ 2490 g (~5 lbs. 8 oz.).
- Infant was identified by parents as very fussy or extremely fussy.
- Infant is exclusively formula-fed at time of study entry. Parent(s) confirm their intention to feed their infant the study product as the sole source of nutrition for the duration of the study.
- Parent(s) confirm their intention not to administer vitamin or mineral supplements, solid foods or juices to their infant from enrollment through the duration of the study.
Exclusion Criteria:
- An adverse maternal, fetal or subject medical history that is thought by the investigator to have potential for effects on tolerance, growth, and/or development.
- Subject is taking and plans to continue medications, home remedies (such as juice for constipation), herbal preparations or rehydration fluids that might affect GI tolerance.
- Subject participates in another study that has not been approved as a concomitant study.
- Subject has been fed any formula containing human milk oligosaccharides prior to study enrollment.
- Subject has been treated with oral antibiotics within 7 days prior to study enrollment.
- Mother intends to use a combination of breast and formula feeding.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: OTHER
- Allocation: NA
- Interventional Model: SINGLE_GROUP
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Infant formula supplemented with prebiotics
infant formula powder, feed ad libitum
|
Sole source nutrition
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fussiness
Time Frame: Change from baseline (3 days prior to study day 1) to within 1 day of initiation of study feeding
|
Parent questionnaires
|
Change from baseline (3 days prior to study day 1) to within 1 day of initiation of study feeding
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fussiness
Time Frame: Baseline to Day 29
|
Parent Questionnaires
|
Baseline to Day 29
|
Hours of Daily Crying
Time Frame: Baseline to Day 29
|
Parent Questionnaires
|
Baseline to Day 29
|
Gastrointestinal Tolerance
Time Frame: Baseline to Day 29
|
Parent Questionnaires
|
Baseline to Day 29
|
Stool Pattern
Time Frame: Baseline to Day 29
|
Parent Questionnaires
|
Baseline to Day 29
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Chair: Marlene Borschel, PhD, RD, LD, Abbott Nutrition
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ACTUAL)
May 1, 2016
Primary Completion (ACTUAL)
May 2, 2017
Study Completion (ACTUAL)
May 2, 2017
Study Registration Dates
First Submitted
April 28, 2016
First Submitted That Met QC Criteria
April 29, 2016
First Posted (ESTIMATE)
May 2, 2016
Study Record Updates
Last Update Posted (ACTUAL)
June 19, 2017
Last Update Submitted That Met QC Criteria
June 16, 2017
Last Verified
June 1, 2017
More Information
Terms related to this study
Other Study ID Numbers
- AL20
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Gastrointestinal Tolerance
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Abbott NutritionActive, not recruiting
-
Cambridge GlycoscienceCompletedGastrointestinal ToleranceIreland
-
Tate & LyleBiofortis Innovation ServicesCompletedGastrointestinal ToleranceUnited States
-
Abbott NutritionCompletedGastrointestinal ToleranceTurkey
-
Comet Bio Inc.Biofortis, Merieux NutriSciencesUnknownGastrointestinal Tolerance
-
Abbott NutritionCompleted
-
Abbott NutritionCompleted
-
Nutricia ResearchCompletedGastrointestinal TolerancePoland
Clinical Trials on Infant formula supplemented with prebiotics
-
NestléNational University Hospital, SingaporeCompleted
-
Danone NutriciaNutricia Early Life Nutrition (Shanghai) Co., LtdCompletedHealthy InfantsChina
-
FrieslandCampinaTerminated
-
Abbott NutritionCompleted
-
Biostime, Inc.University of California, Davis; University of Illinois at Urbana-Champaign; Children... and other collaboratorsUnknownGrowth | Health | Immune FunctionsChina
-
Beneo-InstituteUniversitair Ziekenhuis BrusselNot yet recruitingChild Development | Diet, Healthy
-
Nutricia ResearchCompletedGrowthFrance, Spain, Netherlands, Poland, Finland, Germany
-
Mead Johnson NutritionUniversity of Kansas Medical CenterCompletedBehavioral Measures of ToleranceUnited States
-
NestléCompletedGastro-intestinal Infections | Infections With FeverFrance, Germany, Netherlands
-
HiPP GmbH & Co. Vertrieb KGUniversity Multiprofile Hospital for Active Treatment Dr. Georgi Stranski...Active, not recruitingGut MicrobiotaBulgaria